You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
CMEC Meeting 55, 17 February 2006
Complementary Medicines Evaluation Committee
Extracted ratified minutes
Public recommendation summary
This summary has been posted immediately after the CMEC meeting to give quick advice of the recommendations made by CMEC to the TGA. This summary does not represent the decisions of TGA. Reasons underlying these recommendations will be available after Members ratify the Minutes at the next CMEC meeting.
CMEC confirms that the draft Minutes of its previous meeting (CMEC 54, 9 December 2005), as amended, are a true and accurate record of that meeting.
CMEC recommends to the TGA that Trametes versicolor proteoglycan concentrate is suitable for use as an active ingredient in oral Listed medicines.
|Complementary Medicines Evaluation Committee meeting 55 (pdf)||66KB|